(Q43752331)

26 November 2017

Complement activation contributes to the injury and outcome of kidney in human anti-glomerular basement membrane disease (English)

1 reference

26 November 2017

Rui Ma

1

1 reference

26 November 2017

Zhao Cui

series ordinal

2

1 reference

26 November 2017

Yun-hua Liao

series ordinal

3

1 reference

26 November 2017

Ming-hui Zhao

series ordinal

4

1 reference

26 November 2017

2 September 2012

1 reference

Journal of Clinical Immunology

26 November 2017

1 reference

26 November 2017

33

1 reference

26 November 2017

172-178

1 reference

26 November 2017

1

1 reference

https://scigraph.springernature.com/pub.10.1007/s10875-012-9772-2

26 November 2017

0 references

cites work

Anti-GBM nephritis in the mouse: severe proteinuria in the heterologous phase

1 reference

https://api.crossref.org/works/10.1007%2FS10875-012-9772-2

Complement: a key system for immune surveillance and homeostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-012-9772-2

Complement and its role in innate and adaptive immune responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-012-9772-2

Synthesis of hydroxyeicosatetraenoic acids and leukotrienes in rat nephrotoxic serum glomerulonephritis. Role of anti-glomerular basement membrane antibody dose, complement, and neutrophiles

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-012-9772-2

The complement system in systemic autoimmune disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-012-9772-2

Eculizumab in a patient with dense-deposit disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-012-9772-2

Eculizumab for the Treatment of Dense-Deposit Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-012-9772-2

Eculizumab and Refractory Membranoproliferative Glomerulonephritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-012-9772-2

Prevention of C5 activation ameliorates spontaneous and experimental glomerulonephritis in factor H-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-012-9772-2

Generation of C5a in the absence of C3: a new complement activation pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-012-9772-2

Accumulation of immune complexes in glomerular disease is independent of locally synthesized c3

21 January 2018

1 reference

12 December 2020

Role of terminal complement pathway in the heterologous phase of antiglomerular basement membrane nephritis

1 reference

12 December 2020

Protection and injury: the differing roles of complement in the development of glomerular injury

1 reference

12 December 2020

Interaction between the coagulation and complement system

1 reference

12 December 2020

Protection against anti-glomerular basement membrane (GBM)-mediated nephritis in C3- and C4-deficient mice

1 reference

12 December 2020

Anti-glomerular basement membrane glomerulonephritis: a morphologic study of 80 cases

1 reference

12 December 2020

Implication of the complement system in the induction of anti-glomerular basement membrane glomerulonephritis in WKY rats

1 reference

12 December 2020

Complement activation products in the urine from proteinuric patients

1 reference

12 December 2020

Both complement and IgG fc receptors are required for development of attenuated antiglomerular basement membrane nephritis in mice

1 reference

12 December 2020

Inhibition of complement factor C5 protects against anti-myeloperoxidase antibody-mediated glomerulonephritis in mice

1 reference

12 December 2020

Characteristics and prognosis of Chinese patients with anti-glomerular basement membrane disease

1 reference

12 December 2020

The prognostic significance in Goodpasture's disease of specificity, titre and affinity of anti-glomerular-basement-membrane antibodies

1 reference

12 December 2020

Measurement of SC5b-9 in urine in patients with the nephrotic syndrome

1 reference

12 December 2020

10.1007/S10875-012-9772-2

Identifiers

DOI

1 reference

Dimensions Publication ID

26 November 2017

0 references

1 reference